The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication
Open accessAbstract
We report the development and isolation of a cell line, termed HepAD38, that replicates human hepatitis B virus (HBV) under conditions that can be regulated with tetracycline. In the presence of the antibiotic, this cell line is free of virus due to the repression of pregenomic (pg) RNA synthesis. Upon removal of tetracycline from the culture medium, the cells express viral pg RNA, accumulate subviral particles in the cytoplasm that contain DNA intermediates characteristic of viral replication, and secrete virus-like particles into the supernatant. Since the HepAD38 cell line can produce high levels of HBV DNA, it should be useful for analyses of the viral replication cycle that depend upon viral DNA synthesis in a synchronized fashion. In addition, this cell line has been formatted into a high-throughput, cell-based assay that permits the large-scale screening of diverse compound libraries for new classes of inhibitors of HBV replication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Knowles, B. B., Howe, C. C., & Aden, D. P. (1980) · Science · doi:10.1126/science.6248960 · Cited by 2,025
Viral Hepatitis and Liver Disease
Vyas, G. N., Dienstag, J. L., & Hoofnagle, J. H. (1985) · Medical Entomology and Zoology · Cited by 1,860
Epidemiology of Hepatocellular Carcinoma
Bosch, F. X., Ribes, J., Cléries, R., & Díaz, M. (2005) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.12.009 · Cited by 1,131
Sells, M. A., Chen, M. L., & Acs, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.4.1005 · Cited by 1,117
THE MOLECULAR BIOLOGY OF THE HEPATITIS B VIRUSES
Ganem, D., & Varmus, H. E. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003251 · Cited by 1,084
A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection
Dienstag, J. L., Perrillo, R. P., Schiff, E. R., Bartholomew, M., Vicary, C., & Rubin, M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512213332501 · Cited by 800
Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism
Cullen, B. R. (1986) · Cell · doi:10.1016/0092-8674(86)90696-3 · Cited by 681
Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification
Summers, J., Smith, P. M., & Horwich, A. L. (1990) · Journal of Virology · doi:10.1128/jvi.64.6.2819-2824.1990 · Cited by 328
[Epidemiology of hepatocellular carcinoma].
Rosellini, S. R., & Miglio, F. (1991) · PubMed · Cited by 326
Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions
Sells, M. A., Zelent, A. Z., Shvartsman, M., & Acs, G. (1988) · Journal of Virology · doi:10.1128/jvi.62.8.2836-2844.1988 · Cited by 268
Molecular virology and pathogenesis of hepatitis B
LAU, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)92249-s · Cited by 211
Korba, B. E., & Gerin, J. L. (1992) · Antiviral Research · doi:10.1016/0166-3542(92)90056-b · Cited by 189
A cell culture assay for compounds which inhibit hepatitis B virus replication
Korba, B. E., & Milman, G. (1991) · Antiviral Research · doi:10.1016/0166-3542(91)90068-3 · Cited by 103
Brook, M. G. (1988) · Journal of Hospital Infection · doi:10.1016/0195-6701(88)90184-3 · Cited by 65
The Effect of Absolute Configuration on the Anti-HIV and Anti-HBV Activity of Nucleoside Analogues
Furman, P. A., Wilson, J. E., Reardon, J. E., & Painter, G. R. (1995) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029500600601 · Cited by 57
Cited by
Silver Nanoparticles Inhibit Hepatitis B virus Replication
Lu, L., Sun, R. W.-Y., Chen, R., Hui, C.-K., Ho, C.-M., Luk, J. M., Lau, G. K., & Che, C.-M. (2008) · Antiviral Therapy · doi:10.1177/135965350801300210 · Cited by 603
Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor
Decorsière, A., Mueller, H., van Breugel, P. C., Abdul, F., Gerossier, L., Beran, R. K., Livingston, C. M., Niu, C., Fletcher, S. P., Hantz, O., et al. (2016) · Nature · doi:10.1038/nature17170 · Cited by 551
Lok, A. S., Zoulim, F., Locarnini, S., Bartholomeusz, A., Ghany, M. G., Pawlotsky, J.-M., Liaw, Y.-F., Mizokami, M., & Kuiken, C. (2007) · Hepatology · doi:10.1002/hep.21698 · Cited by 447
Guo, H., Jiang, D., Zhou, T., Cuconati, A., Block, T. M., & Guo, J.-T. (2007) · Journal of Virology · doi:10.1128/jvi.01123-07 · Cited by 335
Self-citationIwamoto, M., Watashi, K., Tsukuda, S., Aly, H. H., Fukasawa, M., Fujimoto, A., Suzuki, R., Aizaki, H., Ito, T., Koiwai, O., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.12.052 · Cited by 321
Metadata
- Authors
- Ladner, S. K., Otto, M. J., Barker, C. S., Zaifert, K., Wang, G. H., Guo, J. T., Seeger, C., & King, R. W.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1997-08
- Volume
- 41
- Issue
- 8
- Pages
- 1715-1720
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2143233396
- Cited by
- 640
- References
- 16
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.